Searching for a cure, Improving lives

Challenge Events

 

Whether you want to run, cycle, skydive, trek or jog, we have a challenge event to suit you. Check out our various UK and International events.

Whatever challenge you choose, or if you prefer to take on your own event, we at Action Duchenne will be there to support you all the way!

Every mile and hour you train, every £1 you raise will help find a cure for Duchenne muscular dystrophy through innovative research projects, while improving the lives of those affected by the condition.

If you are interested in getting involved in any challenge events for us then please contact our Events Fundraising Officer on 020 8556 9955 or via paulbown@actionduchenne.org

 

Running pic for website test 2      Cycling website pic test one

Trek pic for website test      Skydive pic for website test

EDITORIAL USE ONLY (Left to right) Parallel London ambassadors, paraplegic television personality Sophie Morgan, model Kelly Knox, 12th Earl of Shaftesbury Nick Ashley-Cooper and Tony Heaton, Chief Executive at Shape, attend the launch of Parallel London, a not-for-profit event, which aims to encourage disabled people to be more active and more independent, at Queen Elizabeth Olympic Park in London. PRESS ASSOCIATION Photo. Picture date: Wednesday February 3, 2016. The major national event, which is backed by the Mayor of London, will take place on Sunday 4th September at Queen Elizabeth Olympic Park in London and will include multiple running or walking distances, ranging from 100m to 10km to suit different levels of ability. The emphasis will be on shared experience and celebrating the spirit of togetherness; everyone will be able to participate in the run at the same time and at their own pace. Photo credit should read: Matt Alexander/PA Wire

 

Donate

Support Action Duchenne with a monthly or one off donation

Donate

Events

View our events

View All Events

Registry

Join the DMD registry for access to clinical trials

Register

Summit presents data from Phase 1 clinical programme of lead utrophin modulator, ezutromid

June 22nd, 2017

Summit Therapeutics has today announced the presentation of clinical data from two Phase 1 clinical trials

Tell me more

What Raxone being given approval through the EAMS scheme means for the Duchenne community

June 22nd, 2017

  Over a number of years we have worked closely with Santhera Pharmaceuticals and other

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne